Transcription factors in myeloid-derived suppressor cell recruitment and function

Current Opinion in Immunology

Volumn 23, Issue 2, 2011, Pages 279-285

  Sonda, Nada ^a   Chioda, Mariacristina ^a   Zilio, Serena ^b   Simonato, Francesca ^c   Bronte, Vincenzo ^a  

^a VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c VENETIAN INSTITUTE OF MOLECULAR MEDICINE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN; GRANULOCYTE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 13; INTERLEUKIN 3; INTERLEUKIN 4; STAT1 PROTEIN; STAT2 PROTEIN; STAT3 PROTEIN; TRANSCRIPTION FACTOR;

BONE MARROW CELL; CD8+ T LYMPHOCYTE; CELL ACTIVITY; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL DIFFERENTIATION; CELL MATURATION; HEMATOPOIESIS; HUMAN; IMMUNOREGULATION; MYELOID DERIVED SUPPRESSOR CELL; MYELOPOIESIS; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SUPPRESSOR CELL;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; HUMANS; MYELOID CELLS; NEOPLASMS; TRANSCRIPTION FACTORS;

EID: 79953113052     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coi.2010.12.006     Document Type: Review

References (46)

1. Rosenbauer F., Tenen D.G. Transcription factors in myeloid development: balancing differentiation with transformation. Nat Rev Immunol 2007, 7:105-117.
2. Iwasaki H., Akashi K. Myeloid lineage commitment from the hematopoietic stem cell. Immunity 2007, 26:726-740.
3. Bronte V., Zanovello P. Regulation of immune responses by l-arginine metabolism. Nat Rev Immunol 2005, 5:641-654.
4. Marigo I., Dolcetti L., Serafini P., Zanovello P., Bronte V. Tumor-induced tolerance and immune suppression by myeloid derived suppressor cells. Immunol Rev 2008, 222:162-179.
5. Dolcetti L., Marigo I., Mantelli B., Peranzoni E., Zanovello P., Bronte V. Myeloid-derived suppressor cell role in tumor-related inflammation. Cancer Lett 2008, 267:216-225.
6. Bronte V., Wang M., Overwijk W.W., Surman D.R., Pericle F., Rosenberg S.A., Restifo N.P. Apoptotic death of CD8+ T lymphocytes after immunization: induction of a suppressive population of Mac-1+/Gr-1+ cells. J Immunol 1998, 161:5313-5320.
7. Dolcetti L., Peranzoni E., Ugel S., Marigo I., Fernandez Gomez A., Mesa C., Geilich M., Winkels G., Traggiai E., Casati A., et al. Hierarchy of immunosuppressive strength among myeloid-derived suppressor cell subsets is determined by GM-CSF. Eur J Immunol 2010, 40:22-35.
8. Movahedi K., Laoui D., Gysemans C., Baeten M., Stange G., Van den Bossche J., Mack M., Pipeleers D., Veld P., De Baetselier P., et al. Different tumor microenvironments contain functionally distinct subsets of macrophages derived from Ly6C(high) monocytes. Cancer Res 2010, 70:5728-5739.
9. Porse B.T., Pedersen T.A., Xu X., Lindberg B., Wewer U.M., Friis-Hansen L., Nerlov C. E2F repression by C/EBPalpha is required for adipogenesis and granulopoiesis in vivo. Cell 2001, 107:247-258.
10. Zhang P., Iwasaki-Arai J., Iwasaki H., Fenyus M.L., Dayaram T., Owens B.M., Shigematsu H., Levantini E., Huettner C.S., Lekstrom-Himes J.A., et al. Enhancement of hematopoietic stem cell repopulating capacity and self-renewal in the absence of the transcription factor C/EBP alpha. Immunity 2004, 21:853-863.
11. Ito T., Nishiyama C., Nakano N., Nishiyama M., Usui Y., Takeda K., Kanada S., Fukuyama K., Akiba H., Tokura T., et al. Roles of PU.1 in monocyte- and mast cell-specific gene regulation: PU.1 transactivates CIITA pIV in cooperation with IFN-gamma. Int Immunol 2009, 21:803-816.
12. Iwasaki H., Somoza C., Shigematsu H., Duprez E.A., Iwasaki-Arai J., Mizuno S., Arinobu Y., Geary K., Zhang P., Dayaram T., et al. Distinctive and indispensable roles of PU.1 in maintenance of hematopoietic stem cells and their differentiation. Blood 2005, 106:1590-1600.
13. Iwama A., Zhang P., Darlington G.J., McKercher S.R., Maki R., Tenen D.G. Use of RDA analysis of knockout mice to identify myeloid genes regulated in vivo by PU.1 and C/EBPalpha. Nucleic Acids Res 1998, 26:3034-3043.
14. Wang D., Paz-Priel I., Friedman A.D. NF-kappa B p50 regulates C/EBP alpha expression and inflammatory cytokine-induced neutrophil production. J Immunol 2009, 182:5757-5762.
15. Porta C., Rimoldi M., Raes G., Brys L., Ghezzi P., Di Liberto D., Dieli F., Ghisletti S., Natoli G., De Baetselier P., et al. Tolerance and M2 (alternative) macrophage polarization are related processes orchestrated by p50 nuclear factor kappaB. Proc Natl Acad Sci U S A 2009, 106:14978-14983.
16. von Vietinghoff S., Asagiri M., Azar D., Hoffmann A., Ley K. Defective regulation of CXCR2 facilitates neutrophil release from bone marrow causing spontaneous inflammation in severely NF-kappa B-deficient mice. J Immunol 2010, 185:670-678.
17. Sander L.E., Sackett S.D., Dierssen U., Beraza N., Linke R.P., Muller M., Blander J.M., Tacke F., Trautwein C. Hepatic acute-phase proteins control innate immune responses during infection by promoting myeloid-derived suppressor cell function. J Exp Med 2010, 207:1453-1464.
18. Halene S., Gaines P., Sun H., Zibello T., Lin S., Khanna-Gupta A., Williams S.C., Perkins A., Krause D., Berliner N. C/EBPepsilon directs granulocytic-vs-monocytic lineage determination and confers chemotactic function via Hlx. Exp Hematol 2010, 38:90-103.
19. Liu F., Wu H.Y., Wesselschmidt R., Kornaga T., Link D.C. Impaired production and increased apoptosis of neutrophils in granulocyte colony-stimulating factor receptor-deficient mice. Immunity 1996, 5:491-501.
20. Hirai H., Zhang P., Dayaram T., Hetherington C.J., Mizuno S., Imanishi J., Akashi K., Tenen D.G. C/EBPbeta is required for 'emergency' granulopoiesis. Nat Immunol 2006, 7:732-739.
21. Marigo I., Bosio E., Solito S., Mesa C., Fernandez A., Dolcetti L., Ugel S., Sonda N., Bicciato S., Falisi E., et al. Tumor-induced tolerance and immune suppression depend on the C/EBPbeta transcription factor. Immunity 2010, 32:790-802.
22. Akagi T., Saitoh T., O'Kelly J., Akira S., Gombart A.F., Koeffler H.P. Impaired response to GM-CSF and G-CSF, and enhanced apoptosis in C/EBPbeta-deficient hematopoietic cells. Blood 2008, 111:2999-3004.
23. Zhang H., Nguyen-Jackson H., Panopoulos A.D., Li H.S., Murray P.J., Watowich S.S. STAT3 controls myeloid progenitor growth during emergency granulopoiesis. Blood 2010, 116:2462-2471.
24. Nefedova Y., Nagaraj S., Rosenbauer A., Muro-Cacho C., Sebti S.M., Gabrilovich D.I. Regulation of dendritic cell differentiation and antitumor immune response in cancer by pharmacologic-selective inhibition of the janus-activated kinase 2/signal transducers and activators of transcription 3 pathway. Cancer Res 2005, 65:9525-9535.
25. Xin H., Zhang C., Herrmann A., Du Y., Figlin R., Yu H. Sunitinib inhibition of Stat3 induces renal cell carcinoma tumor cell apoptosis and reduces immunosuppressive cells. Cancer Res 2009, 69:2506-2513.
26. Cheng P., Corzo C.A., Luetteke N., Yu B., Nagaraj S., Bui M.M., Ortiz M., Nacken W., Sorg C., Vogl T., et al. Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein. J Exp Med 2008, 205:2235-2249.
27. Sinha P., Okoro C., Foell D., Freeze H.H., Ostrand-Rosenberg S., Srikrishna G. Proinflammatory S100 proteins regulate the accumulation of myeloid-derived suppressor cells. J Immunol 2008, 181:4666-4675.
28. Munera V., Popovic P.J., Bryk J., Pribis J., Caba D., Matta B.M., Zenati M., Ochoa J.B. Stat 6-dependent induction of myeloid derived suppressor cells after physical injury regulates nitric oxide response to endotoxin. Ann Surg 2010, 251:120-126.
29. Ko J.S., Rayman P., Ireland J., Swaidani S., Li G., Bunting K.D., Rini B., Finke J.H., Cohen P.A. Direct and differential suppression of myeloid-derived suppressor cell subsets by sunitinib is compartmentally constrained. Cancer Res 2010, 70:3526-3536.
30. Tamura T., Nagamura-Inoue T., Shmeltzer Z., Kuwata T., Ozato K. ICSBP directs bipotential myeloid progenitor cells to differentiate into mature macrophages. Immunity 2000, 13:155-165.
31. Scheller M., Foerster J., Heyworth C.M., Waring J.F., Lohler J., Gilmore G.L., Shadduck R.K., Dexter T.M., Horak I. Altered development and cytokine responses of myeloid progenitors in the absence of transcription factor, interferon consensus sequence binding protein. Blood 1999, 94:3764-3771.
32. Stewart T.J., Greeneltch K.M., Reid J.E., Liewehr D.J., Steinberg S.M., Liu K., Abrams S.I. Interferon regulatory factor-8 modulates the development of tumour-induced CD11b+Gr-1+ myeloid cells. J Cell Mol Med 2009, 13:3939-3950.
33. Stewart T.J., Liewehr D.J., Steinberg S.M., Greeneltch K.M., Abrams S.I. Modulating the expression of IFN regulatory factor 8 alters the protumorigenic behavior of CD11b+Gr-1+ myeloid cells. J Immunol 2009, 183:117-128.
34. Gabriele L., Phung J., Fukumoto J., Segal D., Wang I.M., Giannakakou P., Giese N.A., Ozato K., Morse H.C. Regulation of apoptosis in myeloid cells by interferon consensus sequence-binding protein. J Exp Med 1999, 190:411-421.
35. Burchert A., Cai D., Hofbauer L.C., Samuelsson M.K., Slater E.P., Duyster J., Ritter M., Hochhaus A., Muller R., Eilers M., et al. Interferon consensus sequence binding protein (ICSBP; IRF-8) antagonizes BCR/ABL and down-regulates bcl-2. Blood 2004, 103:3480-3489.
36. Holtschke T., Lohler J., Kanno Y., Fehr T., Giese N., Rosenbauer F., Lou J., Knobeloch K.P., Gabriele L., Waring J.F., et al. Immunodeficiency and chronic myelogenous leukemia-like syndrome in mice with a targeted mutation of the ICSBP gene. Cell 1996, 87:307-317.
37. Huang W., Zhou W., Saberwal G., Konieczna I., Horvath E., Katsoulidis E., Platanias L.C., Eklund E.A. Interferon consensus sequence binding protein (ICSBP) decreases beta-catenin activity in myeloid cells by repressing GAS2 transcription. Mol Cell Biol 2010, 30:4575-4594.
38. Poh T.W., Bradley J.M., Mukherjee P., Gendler S.J. Lack of Muc1-regulated beta-catenin stability results in aberrant expansion of CD11b+Gr1+ myeloid-derived suppressor cells from the bone marrow. Cancer Res 2009, 69:3554-3562.
39. Masumi A., Tamaoki S., Wang I.M., Ozato K., Komuro K. IRF-8/ICSBP and IRF-1 cooperatively stimulate mouse IL-12 promoter activity in macrophages. FEBS Lett 2002, 531:348-353.
40. Wang I.M., Contursi C., Masumi A., Ma X., Trinchieri G., Ozato K. An IFN-gamma-inducible transcription factor, IFN consensus sequence binding protein (ICSBP), stimulates IL-12 p40 expression in macrophages. J Immunol 2000, 165:271-279.
41. Gallina G., Dolcetti L., Serafini P., De Santo C., Marigo I., Colombo M.P., Basso G., Brombacher F., Borrello I., Zanovello P., et al. Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells. J Clin Invest 2006, 116:2777-2790.
42. Kusmartsev S., Gabrilovich D.I. STAT1 signaling regulates tumor-associated macrophage-mediated T cell deletion. J Immunol 2005, 174:4880-4891.
43. Kusmartsev S.A., Li Y., Chen S.H. Gr-1+ myeloid cells derived from tumor-bearing mice inhibit primary T cell activation induced through CD3/CD28 costimulation. J Immunol 2000, 165:779-785.
44. Leung S., Qureshi S.A., Kerr I.M., Darnell J.E., Stark G.R. Role of STAT2 in the alpha interferon signaling pathway. Mol Cell Biol 1995, 15:1312-1317.
45. Corzo C.A., Condamine T., Lu L., Cotter M.J., Youn J.I., Cheng P., Cho H.I., Celis E., Quiceno D.G., Padhya T., et al. HIF-1alpha regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment. J Exp Med 2010, 207:2439-2453.
46. Doedens A.L., Stockmann C., Rubinstein M.P., Liao D., Zhang N., DeNardo D.G., Coussens L.M., Karin M., Goldrath A.W., Johnson R.S. Macrophage expression of hypoxia-inducible factor-1 alpha suppresses T-cell function and promotes tumor progression. Cancer Res 2010, 70:7465-7475.